首页> 外文期刊>Cytotherapy >PHASE II CLINICAL TRIAL OF ALLODEPLETED T CELL IMMUNOTHERAPY (ATIR101) POST-TRANSPLANT RESULTS IN DECREASED TRANSPLANT-RELATED MORTALITY AND IMPROVED SURVIVAL IN ACUTE LEUKEMIA PATIENTS UNDERGOING T-DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION
【24h】

PHASE II CLINICAL TRIAL OF ALLODEPLETED T CELL IMMUNOTHERAPY (ATIR101) POST-TRANSPLANT RESULTS IN DECREASED TRANSPLANT-RELATED MORTALITY AND IMPROVED SURVIVAL IN ACUTE LEUKEMIA PATIENTS UNDERGOING T-DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION

机译:进行T缺失的半透明性干细胞移植的急性白血病患者移植后相关死亡率降低和存活率提高的同种异体T细胞免疫治疗(ATIR101)II期临床试验

获取原文
获取原文并翻译 | 示例
       

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号